A clinical trail to know the efficacy of Homoeopathic medicine as an adjuvant therapy to Standard treatment in COVID-19 patients
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 3: B25-B34- Other viral diseases
- Registration Number
- CTRI/2020/09/028164
- Lead Sponsor
- ational institute of Homoeopathy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Hospitalized patients with confirmed COVID-19 with a clinical categorization of mild and moderate
2.Age between 18 years to 80 years of both gender
1.Patients with severe or critical COVID-19 infection.
2.Persons with severe primary respiratory disease or other pneumonia
3.Pregnant women
4.Persons with severe medical conditions requiring intensive managements
5.COVID-19 positive cases participating as subjects in the interventional arm of other COVID-19 clinical trials
6.Patients who have received organ transplantation in the past 6 months or planning surgery.
7.Patients with complications of Diabetes, Severe Heart, Liver, kidney, brain, blood disease.
8.Patients with any active malignancy.
9.Septicemia/Multi organ failure syndrome.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method